Data gathered: July 1
AI Stock Analysis - Tempus AI (TEM)
Analysis generated June 26, 2025. Powered by Chat GPT.
Tempus AI is a prominent player in the artificial intelligence sector, known for its innovative solutions and rapid growth. The company has established itself as a key player through its advanced AI-driven products and services that cater to a wide array of industries. With its headquarters located in a tech hub, Tempus AI continuously attracts top-tier talent and investment, positioning itself for sustained growth.
Stock Alerts - Tempus AI (TEM)
 |
Tempus AI | July 1 Price is down by -7.4% in the last 24h. |
|
Tempus AI | June 26 News Alert: TEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEM |
|
Tempus AI | June 24 Employee Rating is down by 3.2% over the last month. |
|
Tempus AI | June 21 Insider Alert: LEFKOFSKY ERIC P is selling shares |
Download our app to get future alerts delivered in real-time.
Alternative Data for Tempus AI
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 192 | Sign up | Sign up | Sign up |
| Sentiment | 98 | Sign up | Sign up | Sign up |
| Webpage traffic | 130,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | 22 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 2,708 | Sign up | Sign up | Sign up |
| Reddit Mentions | 9 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 284 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 16,588 | Sign up | Sign up | Sign up |
| Twitter Followers | 11,195 | Sign up | Sign up | Sign up |
| Twitter Mentions | 531 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 2,510 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 49 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,801 | Sign up | Sign up | Sign up |
About Tempus AI
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.
| Price | $59.45 |
| Target Price | Sign up |
| Volume | 15,390,000 |
| Market Cap | $11.5B |
| Year Range | $31.83 - $89.44 |
| Dividend Yield | 0% |
| Analyst Rating | 57% buy |
| Industry | Health Care Services |
In the news
Deadline Alert: Tempus AI, Inc. (TEM) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitJuly 1 - GlobeNewswire |
|
DEADLINE ALERT for VSTS, RCKT, TEM, and DDD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of ShareholdersJuly 1 - GlobeNewswire |
|
TEMPUS AI, INC. (NASDAQ: TEM) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Tempus AI, Inc. Investors of Upcoming DeadlineJune 30 - GlobeNewswire |
|
DEADLINE ALERT for RCKT, DDD, TEM: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class ActionsJune 30 - GlobeNewswire |
|
Tempus AI, Inc.(NasdaqGS: TEM) added to Russell Midcap Growth IndexJune 30 - Finnhub |
|
TEM Investors Have Opportunity to Lead Tempus AI, Inc. Securities Fraud Lawsuit with the Schall Law FirmJune 30 - Finnhub |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 256M | 101M | 155M | -68M | -69M | -0.240 |
| Q4 '24 | 201M | 79M | 122M | -13M | 12M | -0.180 |
| Q3 '24 | 181M | 78M | 103M | -76M | -51M | -0.250 |
| Q2 '24 | 166M | 94M | 72M | -552M | -530M | -0.630 |
| Q1 '24 | 146M | 71M | 75M | -65M | -42M |
Insider Transactions View All
| LEFKOFSKY ERIC P filed to sell 9,355,483 shares at $67.3. June 20 '25 |
| LEFKOFSKY ERIC P filed to sell 9,307,283 shares at $71.2. June 20 '25 |
| LEFKOFSKY ERIC P filed to sell 15,619,026 shares at $67.2. June 20 '25 |
| LEFKOFSKY ERIC P filed to sell 9,312,112 shares at $70.4. June 20 '25 |
| LEFKOFSKY ERIC P filed to sell 9,343,732 shares at $68.7. June 20 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rob Bresnahan |
Jun 10, 25 | Buy | $1K - $15K |
| Nancy Pelosi |
Jan 20, 25 | Buy | $50K - $100K |
Read more about Tempus AI (TEM) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Tempus AI?
The Market Cap of Tempus AI is $11.5B.
What is the current stock price of Tempus AI?
Currently, the price of one share of Tempus AI stock is $59.45.
How can I analyze the TEM stock price chart for investment decisions?
The TEM stock price chart above provides a comprehensive visual representation of Tempus AI's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Tempus AI shares. Our platform offers an up-to-date TEM stock price chart, along with technical data analysis and alternative data insights.
Does TEM offer dividends to its shareholders?
As of our latest update, Tempus AI (TEM) does not offer dividends to its shareholders. Investors interested in Tempus AI should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Tempus AI?
Some of the similar stocks of Tempus AI are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.